- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18:59 | Bone Biologics Prices $5 Mln Public Offering With Warrants At $4 Per Share | - | RTTNews | ||
| 16:42 | Why Is Bone Biologics Stock Surging On Friday? | 4 | Benzinga.com | ||
| 15:24 | Bone Biologics prices $5M public offering with warrants; shares up 45% | 1 | Seeking Alpha | ||
| 13:59 | Why Bone Biologics Is Rising In Pre-market? | 2 | RTTNews | ||
| Do | Bone Biologics Corp - 8-K, Current Report | 1 | SEC Filings | ||
| Do | Bone Biologics regains Nasdaq compliance with minimum bid price rule; shares down | 1 | Seeking Alpha | ||
| Di | Bone Biologics files $35M mixed shelf offering | 7 | Seeking Alpha | ||
| BONE BIOLOGICS Aktie jetzt für 0€ handeln | |||||
| Di | Bone Biologics Corp - S-1, General form for registration of securities | 2 | SEC Filings | ||
| 06.06. | Bone Biologics plunges after announcing 1-for-6 reverse stock split | 2 | Seeking Alpha | ||
| 06.06. | Bone Biologics kündigt Aktienzusammenlegung im Verhältnis 1:6 an | 2 | Investing.com Deutsch | ||
| 06.06. | Bone Biologics announces 1-for-6 reverse stock split | 1 | Investing.com | ||
| 06.06. | Bone Biologics Corporation Announces 1-for-6 Reverse Stock Split | 839 | Business Wire | TYSONS CORNER, Va.--(BUSINESS WIRE)--Strategy (Nasdaq: MSTR/STRK/STRF) today announced the pricing of its initial public offering on June 5, 2025 of 11,764,700 shares of 10.00% Series A Perpetual Stride... ► Artikel lesen | |
| 30.05. | Aktionäre von Bone Biologics genehmigen wichtige Vorschläge | - | Investing.com Deutsch | ||
| 30.05. | Bone Biologics Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 12.05. | Bone Biologics Corp - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 01.04. | Bone Biologics Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 26.02. | Bone Biologics Corp - 10-K, Annual Report | 1 | SEC Filings | ||
| 01.08.24 | Pre-market Movers: Bone Biologics, Immuneering, ALX Oncology, CareDx, MediaAlpha | 745 | AFX News | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.40 A.M. ET).In the Green Bone Biologics Corporation (BBLG) is up over 61%... ► Artikel lesen |
18 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,105 | -1,87 % | Sernova Biotherapeutics, Inc.: Sernova Appoints Jonathan Rigby as Interim Chair | LONDON, Ontario and BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,745 | +0,13 % | Atossa Genetics Year-end 2024 slides: (Z)-endoxifen shows promise, expenses decline | ||
| PING AN HEALTHCARE | 0,946 | +9,49 % | PA GOODDOCTOR (01833): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 26 JUNE 2025 | ||
| MOUNTAIN VALLEY MD | 0,002 | -50,00 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
| CO-DIAGNOSTICS | 0,242 | +4,31 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
| CYTOSORBENTS | 0,981 | -1,70 % | Cytosorbents Corp: CytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb-ATR | PRINCETON, N.J., June 24, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... ► Artikel lesen | |
| VERU | 0,565 | +1,07 % | Veru Inc.: Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation | --During the Maintenance Period of 12 weeks after discontinuing semaglutide (GLP-1 receptor agonist), placebo group regained 43% of body weight that was previously lost during Phase 2b QUALITY study... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Reports First Quarter 2025 Financial Results and Provides Business Update | Presented new amezalpat mechanism-of-action data reinforcing its potential as a novel cancer treatment at the 2025 AACR Annual MeetingGranted Orphan Drug designation by FDA for TPST-1495 for the treatment... ► Artikel lesen | |
| VOLITIONRX | 0,750 | 0,00 % | VOLITIONRX LTD - 8-K, Current Report | ||
| EKSO BIONICS | 3,440 | -4,44 % | XFRA 23E0: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILEKSO BIONICS. NEW... ► Artikel lesen | |
| IMUNON | 0,665 | -2,92 % | H.C. Wainwright reiterates buy rating on Imunon stock at $14 target | ||
| BEYOND AIR | 0,146 | +3,55 % | Beyond Air-Aktionäre genehmigen Reverse-Aktiensplit | ||
| AVINGER | 0,340 | -6,08 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| NOVACYT | 0,492 | +1,97 % | Novacyt S.A. - Result of AGM | ||
| AROVELLA THERAPEUTICS | 0,071 | +11,90 % | AROVELLA THERAPEUTICS LIMITED: Application for quotation of securities - ALA |
BONE BIOLOGICS CORP gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 4,670 Euro und damit +15,88 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BONE BIOLOGICS CORP finden Sie auf Wallstreet Online.